ahlam1399
03-17-2016, 12:20 PM
GlaxoSmithKline CEO Witty to bow out in March 2017
LONDON (Reuters) - GlaxoSmithKline said on Thursday its Chief Executive Andrew Witty would retire in 12 months time, after leading the group since 2008, prompting Britain's biggest drugmaker to start a formal search for his successor.
http://rc.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/rc/1/rc.img (http://rc.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/rc/1/rc.htm)
http://rc.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/rc/2/rc.img (http://rc.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/rc/2/rc.htm)
http://rc.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/rc/3/rc.img (http://rc.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/rc/3/rc.htm)
http://da.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/a2.img (http://da.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/a2.htm)
http://adchoice.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/ach.img (http://adchoice.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/ach.htm)http://pi.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/a2t.imghttp://pi2.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4e528c71/sc/13/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=gvpjkdlrwYY:zUPNpCxIt3w:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=gvpjkdlrwYY:zUPNpCxIt3w:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=gvpjkdlrwYY:zUPNpCxIt3w:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=gvpjkdlrwYY:zUPNpCxIt3w:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=gvpjkdlrwYY:zUPNpCxIt3w:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/gvpjkdlrwYY
LONDON (Reuters) - GlaxoSmithKline said on Thursday its Chief Executive Andrew Witty would retire in 12 months time, after leading the group since 2008, prompting Britain's biggest drugmaker to start a formal search for his successor.
http://rc.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/rc/1/rc.img (http://rc.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/rc/1/rc.htm)
http://rc.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/rc/2/rc.img (http://rc.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/rc/2/rc.htm)
http://rc.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/rc/3/rc.img (http://rc.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/rc/3/rc.htm)
http://da.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/a2.img (http://da.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/a2.htm)
http://adchoice.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/ach.img (http://adchoice.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/ach.htm)http://pi.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/a2t.imghttp://pi2.feedsportal.com/r/247394957121/u/49/f/654207/c/35217/s/4e528c71/sc/13/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4e528c71/sc/13/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=gvpjkdlrwYY:zUPNpCxIt3w:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=gvpjkdlrwYY:zUPNpCxIt3w:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=gvpjkdlrwYY:zUPNpCxIt3w:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=gvpjkdlrwYY:zUPNpCxIt3w:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=gvpjkdlrwYY:zUPNpCxIt3w:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/gvpjkdlrwYY